News Headlines

  1. Fujifilm Establishes The Bio Science & Engineering Laboratories U.S.A. To Start Full-Scale Translational Research For Biotherapeutics In The United States 12/5/2019

    FUJIFILM Corporation (President: Kenji Sukeno) announced that it has begun full-scale research activities to advance the field of translational research for biotherapeutics at its newly established “Bio Science & Engineering Laboratories U.S.A.”

  2. PCI Pharma Services Completes Expansion Of Its Specialty Drug Product Capabilities At Rockford, IL Site 12/4/2019

    PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced the completion of an expansion to its Rockford, IL facility to enhance its Specialty Drug Product Capabilities.

  3. AWS Announces Strategic Collaboration With Novartis To Accelerate Digital Transformation Of Its Business Operations 12/4/2019

    Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), announced a multi-year strategic collaboration with Novartis to reimagine this leading pharmaceutical company’s core pharmaceutical manufacturing, supply chain, and delivery operations using AWS’s portfolio of cloud services.

  4. VGXI Selects BE&K As Design Firm For New 240,000 Square Foot Manufacturing Facility 12/3/2019

    VGXI, a highly regarded CDMO supporting the gene therapy and DNA vaccine industries, announces it has chosen the integrated construction services company BE&K Building Group as Design-Build Partner for the initial phase of its new manufacturing site.

  5. Boehringer Ingelheim Chooses NiceLabel Solution To Help Support Standardized Labeling Worldwide 12/2/2019

    Global pharmaceutical company, Boehringer Ingelheim, has selected NiceLabel, a leading global developer of label design software and label management systems, to help it create a global standardized labeling process.

  6. Astellas Buys Audentes Therapeutics For $3B For Gene Therapy Drug Manufacturing Expansion 12/2/2019

    Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Audentes Therapeutics, Inc. (Chairman and CEO: Matthew R. Patterson, “Audentes”), today announced that they have entered into a definitive agreement for Astellas to acquire Audentes at a price of US$60.00 per share in cash, representing a total equity value of approximately US$3B.

  7. Speeding Cell, Gene Therapy Development 11/25/2019

    An innovative new major private-public partnership led by Harvard and MIT aims to accelerate one of the hottest and most promising areas of medical research: cell and gene therapy

  8. Heraeus Expands Cancer Therapy API Capacity 11/22/2019

    Heraeus Pharmaceutical Ingredients, a business line of Heraeus Precious Metals, has expanded its capacity for Platinum-based highly potent active pharmaceutical ingredients (Pt HPAPIs) with an additional production line built at the company’s headquarters in Hanau, Germany.

  9. WuXi Vaccines To Build A $240M Manufacturing Facility In Ireland 11/22/2019

    WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in human vaccine Contract Development and Manufacturing Organization (CDMO) business, is to invest 240 million USD and build a new vaccine manufacturing facility in Ireland.

  10. AstraZeneca Partnership Gives Significant Boost To Sun Pharma’s Overall China Entry Strategy, Says GlobalData 11/21/2019

    Sun Pharmaceutical Industries Ltd (Sun Pharma) has recently entered into a licensing agreement with AstraZeneca UK to launch novel ready-to-use oncology drugs in China.